COVID-19 pandemic Swissmedic approves the use of the monoclonal antibody cocktail Ronapreve developed by Roche and Regeneron to treat severe COVID-19 patients. Swiss regulator approves Roche-Regeneron Covid-19 drug © Swissinfo Sources: Swissinfo
